OPENING

07.30h UTC 

Los Angeles-8h, Chicago-6h, Mexico City -6h, New York-5h, Panama -5h, Ouagadougou +0h, London +0h, Madrid +1h, Paris +1h, Rome +1h, Amsterdam +1h, Berlin +1h, Abuja +1h, Bucharest +2h, Helsinki +2, Cape Town +2h, Addis Ababa +3h, Nairobi +3h, Riyadh +3h, Tiblisi +4h, Abu Dhabi +4h, New Delhi +5.30h, Jakarta +7h, Beijing +8h, Tokyo +9h, Sydney +11h

——–

Massimo Sartelli (Italy)

World Antimicrobial Awareness Week (WAAW ) 2022

Diriba Mosissa (Antimicrobial Stewardship and Awareness Unit, Division of Antimicrobial Resistance, WHO)

—–

The importance of a multidisciplinary approach in preventing and treating infections in healthcare

Silvio Brusaferro (Italian National Institute of Health)

Infection prevention and management: why it’s so hard to really change our behavior

Maria Luisa Moro (Italian Multidisciplinary Society for the Prevention of Infections in Healthcare Organizations)

—-

Education and training in antimicrobial stewardship

Dilip Nathwani (Global Antimicrobial Stewardship Partnership Hub)

—–

SESSION 1

APPROPRIATE USE OF ANTIBIOTICS AND UNCONVENTIONAL THERAPY

08.45h UTC

Moderated by

Leonardo Pagani (Italy)

—–

Why prudent use of antibiotics

Pierre Tattevin (Alliance for the Prudent Use of Antibiotics)

——

Defining the impact of antibiotics on the intestinal microbiota to optimize antibiotic usage

Etienne Ruppe (France)

——

Phage therapy for multi-drug resistant Infections: certainties and controversies

Mariagrazia Di Luca (Italy)

—-

How to improve antibiotic awareness

Francesca Chiara (Antimicrobial Stewardship Project, Center for Infectious Disease Research and Policy)

—-

Invited to comment

Maria Elena Cocuz (Romania), Rahul Kamble (India)

——–

OPENING SESSION

THE GLOBAL BURDEN OF ANTIMICROBIAL RESISTANCE

10.15h UTC

Moderated by Fausto Catena (Italy)

—–

One health approach to tackling antimicrobial resistance

Sujith J. Chandy (ReAct Asia Pacific, India)

—-

The overlooked pandemic of antimicrobial resistance

Geetanjali Kapoor (Center for Disease Dynamics, Economics & Policy)

—-

Global priority research agenda on antimicrobial resistance in the human health sector

Silvia Bertagnolio (Control and Response Strategies Unit, Department of Control, Surveillance and Prevention of Antimicrobial Resistance, WHO)

—–

The European Union’s vision for antimicrobial resistance

John F. Ryan (Public health, country knowledge, crisis management, DG SANTE, European Commission, European Union)

—-

INTRA-ABDOMINAL INFECTIONS

SESSION 2

11:30h UTC

Moderated by

Vishal Shelat (Singapore)

—-

Classifications for intra-abdominal infections

Matti Tolonen (Finland)

—–

How to diagnose intra-abdominal infections

Sanjay Marwah (India)

—-

Prognostic scores for intra-abdominal infections. Can they be used in clinical practice?

Fikri Abu-Zidan (United Arab Emirates)

——

Invited to comment

Syed Muhammad Ali (Qatar), Gia Tomadze (Giorgia), Igor A. Kryvoruchko (Ukraine)

——

12.45 h UTC

Research in surgical infections: obstacles and opportunities (from APPAC I to APPAC III)

Paulina Salminen (Finland)

——

INTRA-ABDOMINAL INFECTIONS

SESSION 3

13.05h UTC

Moderated by

Luca Ansaloni (Italy)

Source control in intra-abdominal infections

Federico Coccolini (Italy)

——

Peritoneal swabs: when and how

Andreas Hecker (Germany)

—–

Microbiological tests in the era of antimicrobial resistance

Warren Lowman (South Africa)

——

Invited to comment

Ibrahima Sall (Senegal), Andee Dzulkarnaen Zakaria (Malaysia)

—–

INTRA-ABDOMINAL INFECTIONS

SESSION 4

14:20h UTC

Moderated by

Boris Sakakushev (Bulgaria)

—–

The ongoing threat of antimicrobial resistance in Gram-negative bacteria

Jesús Rodríguez Baño (Spain)

—–

Principles of antibiotic therapy in patients with intra-abdominal infections

Pierluigi Viale (Italy)

——

Optimal duration of antibiotic therapy for intra-abdominal infections

Robert Sawyer (USA)

—–

Invited to comment

Tadeja Pintar (Slovenia), Sumita Agarwal Jain (India)

—–

INTRA-ABDOMINAL INFECTIONS

SESSION 5

15:35h UTC

Moderated by

Raul Coimbra (USA)

—–

Invasive candidiasis in patients with intra-abdominal infections. When and how to treat intra-abdominal candidiasis

Philippe Montravers (France)

—-

Management of intra-abdominal infections in critically ill patients

Therese Duane (USA)

—–

Principles of antibiotic therapy in critically ill patients

Jan J De Waele (Belgium)

—–

Invited to comment

Samir Delibegovic (Bosnia and Herzegovina), Adrien Hodonou (Benin)

—–

16:50h UTC

The role of surgeons in preventing and treating infections in surgery

E. Patchen Dellinger (USA)

——

INTRA-ABDOMINAL INFECTIONS

SESSION 5

17:15h UTC

Moderated by

Mauro Podda (Italy)

—–

The management of intra-abdominal infections and sepsis in elderly critically ill patients: defining the line between utility and futility.

Massimo Antonelli (Italy)

—-

Relaparotomy strategy. When and how.

Marja Boermeester (The Netherlands)

—–

Damage control surgery strategy in patients with severe intra-abdominal infections.

Andrew Kirkpatrick (Canada)

—–

Invited to comment

Alibrahim Yahya (Libia), Carlos Augusto Gomes (Brazil)

—–

ANTIMICROBIAL STEWARDSHIP

SESSION 6

18:30h UTC

Moderated by Fabio Tumietto (Italy) 

—-

Core components of global antimicrobial stewardship programs

Debra Goff (USA)

—–

Antimicrobial Stewardship in resource-poor settings

Abdoul Salam Ouédraogo (Burkina Faso)

—–

COVID-19 and antimicrobial stewardship lessons learned best practices and future implications

Alfredo Ponce-de-Leon (Mexico)

—–

Measurement of Performance in Antimicrobial Stewardship

Majdi N Al-Hasan (USA) 

——

Invited to comment

Ana Belén Araúz (Panama), Abdul-Wahab Omo-ope Ettu (Nigeria)

——

20:00h UTC

Together we can impact millions of people. Achieving better health outcomes for vulnerable populations and communities through collaborative research

Tanya Zakrison (USA)

CLOSING

20.20h UTC